ALBIO.PAライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (1 5月 2024 @ 00:35):

Stats
本日の出来高	5 876.00
平均出来高	9 830.00
時価総額	45.20M
EPS	€0 ( 2024-04-20 )
次の収益日	( €0 ) 2024-05-27
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-1.240
ATR14	€0.0260 (0.63%)

Biosynex SA 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Biosynex SA 財務諸表

Annual	2022
収益:	€196.59M
総利益:	€64.52M (32.82 %)
EPS:	€1.520

FY	2022
収益:	€196.59M
総利益:	€64.52M (32.82 %)
EPS:	€1.520

FY	2021
収益:	€382.53M
総利益:	€206.41M (53.96 %)
EPS:	€10.08

FY	2020
収益:	€153.90M
総利益:	€69.32M (45.04 %)
EPS:	€3.52

Financial Reports:

No articles found.

Biosynex SA

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.